1. Manual Exchange Peritoneal Dialysis
2. Baxter Peritoneal Dialysis

Overview

The Chronic Ambulatory Peritoneal Dialysis (CAPD) program is an outpatient service for home peritoneal dialysis patients. Our goal is to provide a collaborative environment in which patients and families can be trained, supported, and followed. This program has a multidisciplinary approach staffed by Mass General Nephrologists, renal nurses, a dietician, and a social worker who provide the support needed to the home peritoneal dialysis patient. Additional services provided include interventions for dialysis related issues and inpatient consultations.

Download Citation On Aug 1, 2011, Ramesh Saxena published Growing a peritoneal dialysis program: A single‐center experience Find, read and cite all the research you need on ResearchGate.

The Chronic Ambulatory Peritoneal Dialysis (CAPD) program is a self-dialysis procedure that is done by the patient or a trained helper at home. Training is provided and tailored to the patient's readiness to learn. Consistent follow-up with the nephrologists, nurses, and dietician is necessary for patient well-being.

1. Growing a peritoneal dialysis program: A single-center experience. Dialysis and Transplantation. 2011 Aug;40(8):343-348.
2. Enough dialysis. If so, your doctor may need to change your dialysis prescription or other medical care that you are receiving. Your peritoneal equilibration test (PET) This test is done within 4–8 weeks after starting peritoneal dialysis. It tells how your peritoneal membrane is working and helps your doctor decide how many exchanges you.
3. Peritoneal dialysis. During peritoneal dialysis, a cleansing fluid (dialysate) is circulated through a tube (catheter) inside part of your abdominal cavity (peritoneal cavity). The dialysate absorbs waste products from blood vessels in your abdominal lining (peritoneum) and then is drawn back out of your body and discarded.

DUBLIN--(BUSINESS WIRE)--The 'Peritoneal Dialysis Market Share, Size and Growth, By Type, By End-User By Product And Segment Forecasts, 2016-2026' report has been added to ResearchAndMarkets.com's offering.

Increasing occurrences of renal failure due to hypertension, stress, and diabetes mellitus globally, are the major factors influencing the market growth.

The Peritoneal Dialysis Market is estimated to reach USD 5.58 Billion by 2027. This can be mainly associated with the growing incidences of chronic diseases and technological advancements that are expected to become the most common growth factors globally in the coming years.

Peritoneal dialysis (PD) is a method of dialysis that uses dialysis solution and the inner lining of the abdomen to drain blood when the kidneys are not functioning efficiently. This method is mostly performed at home and principally works to remove excess waste products and fluid from the blood. ESRD (End-stage renal disease), which is generally known as kidney failure, is a significant factor for the growth of the market. Diabetes is the most common cause of ESRD, whereas high blood pressure is the second most common cause of ESRD. High blood pressure and diabetes are the most common chronic disease among the global population, and a shortage of kidneys for transplantation due to stringent regulations regarding kidney transplantation in several countries are some of the factors that are responsible for stimulating the market growth. However, the lack of awareness and limited demand in underdeveloped countries are some factors that may hinder the market growth. The rise in demand for home peritoneal dialysis treatment and increased opportunities in weak and emerging markets would create future opportunities.

Due to the presence of key players, favorable reimbursement policies, and a rising number of chronic diseases, and several initiatives by the government, North America accounts for the largest share of around 35.3% of the market by 2019.

Further key findings from the report suggest

• Peritoneal dialysis is the cleansing of blood and the elimination of extra fluids by using the peritoneal membrane, the body's natural filter.
• Hemodialysis is a method of pumping out the blood to an artificial kidney system and is returned to the body with the help of tubing accessories.
• The peritoneal membrane is the lining that circles the abdominal cavity, including the stomach, spleen, liver, and intestines.
• CAPD type segment is expected to grow at a rate of 5.4% during the forecast period due to portability, low cost, and freedom from machines.
• The growing population, increasing rates of chronic diseases, and rising healthcare expenditure are the fundamental factors that are boosting the growth of the market across the globe.
• A growing aging population that needs long term care requirements, raising awareness about hospital-acquired infections, and growing usage of technologies among patients are few factors that are expected to expand usage rates.
• The hospital-based dialysis segment accounts for a market share of approximately 31.2% by 2019.
• Innovative product development and collaborative developments are some critical strategic initiatives taken by the players in this industry to fortify their position in the competition.
• The presence of unique diagnostic and therapeutic medical technologies that enable quick and accurate diagnosis is the primary factor for the growth of this segment.
• The benefits of peritoneal dialysis involve no use of needles, minimum clinic visits, and continuous therapy supplies similar to the kidney's natural functioning.
• The peritoneal dialysis solution segment accounted for the largest share of nearly 23.3% by 2019.
• Europe accounted for a share of about 26.3% in 2019 and is expected to grow at a rate of 5.3% during the forecast period.
• Key participants include Nipro, Covidien, B. Braun Melsungen, Diversified Specialty Institute Holdings, DaVita Healthcare Partners, Baxter International, Dialysis Clinic, Medical Components, Northwest Kidney Centers, Fresenius Medical Care, Huaren Pharmaceutical, NephroPlus, Satellite Healthcare, NxStage Medical, Renal Services, Sandor, Sichuan Kelun Pharmaceutical, and U.S. Renal Care.

Key Topics Covered:

Chapter 1. Market Synopsis

Chapter 2. Executive Summary

Chapter 3. Indicative Metrics

Chapter 4. Peritoneal Dialysis Market Segmentation & Impact Analysis

Chapter 5. Peritoneal Dialysis Market By Type Insights & Trends

Chapter 6. Peritoneal Dialysis Market By End-User Insights & Trends

Chapter 7. Peritoneal Dialysis Market By Product Insights & Trends

Chapter 8. Peritoneal Dialysis Market Regional Outlook

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

• Baxter International
• Nipro
• B. Braun Melsungen
• DaVita Healthcare Partners Co.idien
• Dialysis Clinic
• Fresenius Medical Care
• Diversified Specialty Institute Holdings
• Medical Components
• Huaren Pharmaceutical
• NephroPlus
• Northwest Kidney Centers
• Satellite Healthcare
• NxStage Medical
• Renal Services
• Sandor
• Sichuan Kelun Pharmaceutical
• U.S. Renal Care

Manual Exchange Peritoneal Dialysis

For more information about this report visit https://www.researchandmarkets.com/r/1bz8v0

About ResearchAndMarkets.com

Baxter Peritoneal Dialysis

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.